Oxymorphone Hydrochloride Tablet
Product Images NDC 63629-1926

5 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Oxymorphone Hydrochloride (NDC 63629-1926). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Struct (Structure)

Struct (Structure)
Chemical structure of oxymorphone hydrochloride, showing its molecular framework including hydroxyl groups, ketone groups, and the hydrochloride component.*
FDA Label Image

Table 2 (Table 2)

Table 2 (Table 2)
This image is a text panel discussing drug interactions for oxymorphone hydrochloride tablets. It details clinical impacts, interventions, and examples of interacting drug classes including alcohol, benzodiazepines, CNS depressants, serotonergic drugs, MAOIs, opioid agonists/antagonists, muscle relaxants, diuretics, anticholinergic drugs, and cimetidine, emphasizing management recommendations to avoid adverse effects.*
FDA Label Image

Table 1 (Table 1)

Table 1 (Table 1)
A table showing adverse reactions reported in placebo-controlled trials comparing oxymorphone hydrochloride tablets (N=557) to placebo (N=270). It lists percentages of side effects such as nausea, pyrexia, somnolence, vomiting, pruritus, headache, dizziness excluding vertigo, constipation, and confusion for each group.*
FDA Label Image

Table 3 (Table 3)

Table 3 (Table 3)
A data table titled 'Mean (±SD) Oxymorphone Hydrochloride Tablets Pharmacokinetic Parameters' presenting pharmacokinetic values for oxymorphone hydrochloride tablets at dosages of 5 mg, 10 mg, and 20 mg. It shows Cmax (ng/mL), AUC (ng·hr/mL), and T1/2 (hr) for single and multiple doses, with notes on dosing frequency and non-applicable values for half-life in multiple doses.*
FDA Label Image

Label (Lbl636291926)

Label (Lbl636291926)
Label for Oxymorphone Hydrochloride Tablets USP 5 mg by Bryant Ranch Prepack. The label includes the NDC 63629-1926-1, dosage strength 5 mg, quantity of 100 tablets, and the BRP Pharmaceuticals logo. It notes storage instructions, child-resistant packaging, and a caution about overdose and addiction risk.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.